Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

News Daily News

Making Sense of Masters Athletes’ Cardiac Imaging: Expert Review

Michael O'Riordan

December 11, 2025

News Industry News

CellProthera announces positive Phase I/IIb data for ProtheraCytes® cell therapy in acute myocardial infarction

May 29, 2024

News Daily News

Exercise Keeps Athletic Heart Supple, Strong, Healthy: JACC Deep Dive

Michael O'Riordan

September 09, 2022

News Daily News

AHA Urges More Home-Based Dialysis in Advanced Kidney Failure

Michael O'Riordan

August 18, 2022

News Opinion CV Team Dispatch

January 2021 News Roundup

L.A. McKeown

January 01, 2021

News Conference News ESC 2019

Stopped Early, DAPA Offers Insight on ICD Timing After STEMI

Shelley Wood

September 04, 2019

News Daily News

Silent Infarcts Have Similar Mortality Over 10 Years as Clinically Recognized MI

Yael L. Maxwell

October 10, 2018

News Conference News TCT 2015

Despite Setbacks, Research Into Myocardial Salvage Continues

October 12, 2015

News Industry News

Ventrix Initiates Clinical Trial of VentriGel™

September 17, 2015

News Conference News ESC 2015

Failed Trial PRomPTs Questions About Role of Peri-Infarct Pacing for Remodeling of Large MIs

L.A. McKeown

August 30, 2015

News Daily News

Catheter-Delivered Gene Therapy Yields Positive Signal in Advanced Heart Failure

June 23, 2015

News Daily News

Registry Study: Survival Benefit for Treating CTO After Primary PCI

Todd Neale

October 10, 2014

News Conference News ESC 2014

NOMI: Nitric Oxide May Do Wonders for STEMI But Not When Mixed with Nitroglycerin

Caitlin E. Cox

September 01, 2014

News Daily News

REMINDER Study: Eplerenone Safe, Effective in STEMI Patients Without Heart Failure

May 05, 2014

News Daily News

Distal Protection Adds Early Boost to Thrombectomy in STEMI, but No Lasting Benefit

L.A. McKeown

September 27, 2013

Presentation TCT 2012

TCT-61. Infarct Size-Determined Uptake of CD34+ Cells in the Peri-Infarct Zone and Left Ventricular Remodeling: Insights from Integration of Labeled Cells Uptake SPECT...

Presenter: Piotr Musialek

October 23, 2012

News Daily News

Lack of Benefit, Potential Harm REVEALed with EPO in STEMI Patients

Jason Kahn

May 12, 2011

Advertisement

Making Sense of Masters Athletes’ Cardiac Imaging: Expert Review

CellProthera announces positive Phase I/IIb data for ProtheraCytes® cell therapy in acute myocardial infarction

Exercise Keeps Athletic Heart Supple, Strong, Healthy: JACC Deep Dive

AHA Urges More Home-Based Dialysis in Advanced Kidney Failure

January 2021 News Roundup

Stopped Early, DAPA Offers Insight on ICD Timing After STEMI

Silent Infarcts Have Similar Mortality Over 10 Years as Clinically Recognized MI

Despite Setbacks, Research Into Myocardial Salvage Continues

Ventrix Initiates Clinical Trial of VentriGel™

Failed Trial PRomPTs Questions About Role of Peri-Infarct Pacing for Remodeling of Large MIs

Catheter-Delivered Gene Therapy Yields Positive Signal in Advanced Heart Failure

Registry Study: Survival Benefit for Treating CTO After Primary PCI

NOMI: Nitric Oxide May Do Wonders for STEMI But Not When Mixed with Nitroglycerin

REMINDER Study: Eplerenone Safe, Effective in STEMI Patients Without Heart Failure

Distal Protection Adds Early Boost to Thrombectomy in STEMI, but No Lasting Benefit

TCT-61. Infarct Size-Determined Uptake of CD34+ Cells in the Peri-Infarct Zone and Left Ventricular Remodeling: Insights from Integration of Labeled Cells Uptake SPECT...

Lack of Benefit, Potential Harm REVEALed with EPO in STEMI Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content